Manulife (Manufacturers Life Insurance)’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-12,362
Closed -$57K 3002
2019
Q1
$57K Buy
12,362
+2,357
+24% +$11.2K ﹤0.01% 2610
2018
Q4
$35K Sell
10,005
-1,813
-15% -$12.6K ﹤0.01% 2499
2018
Q3
$119K Sell
11,818
-12,090
-51% -$96.4K ﹤0.01% 2881
2018
Q2
$173K Buy
23,908
+2,376
+11% +$16.6K ﹤0.01% 3231
2018
Q1
$130K Sell
21,532
-1,800
-8% -$14.9K ﹤0.01% 3321
2017
Q4
$225K Sell
23,332
-1,394
-6% -$9.12K ﹤0.01% 2913
2017
Q3
$219K Buy
24,726
+3,150
+15% +$32.5K ﹤0.01% 2912
2017
Q2
$274K Buy
21,576
+938
+5% +$11.1K ﹤0.01% 2752
2017
Q1
$217K Buy
20,638
+1,807
+10% +$19.3K ﹤0.01% 2778
2016
Q4
$173K Buy
18,831
+601
+3% +$6.79K ﹤0.01% 2901
2016
Q3
$215K Sell
18,230
-248
-1% -$3.77K ﹤0.01% 2724
2016
Q2
$239K Buy
18,478
+1,413
+8% +$20.6K ﹤0.01% 2583
2016
Q1
$271K Buy
17,065
+161
+1% +$3.06K ﹤0.01% 2385
2015
Q4
$484 Sell
16,904
-64,992
-79% -$1.8M ﹤0.01% 2050
2015
Q3
$2.33K Buy
81,896
+65,478
+399% +$2.41M ﹤0.01% 1340
2015
Q2
$590 Buy
16,418
+1,914
+13% +$59.6K ﹤0.01% 2015
2015
Q1
$211 Buy
14,504
+392
+3% +$10.4K ﹤0.01% 2691
2014
Q4
$297 Sell
14,112
-678
-5% -$13.4K ﹤0.01% 2358
2014
Q3
$287 Buy
14,790
+390
+3% +$6.12K ﹤0.01% 2377
2014
Q2
$225K Buy
14,400
+1,478
+11% +$23.9K ﹤0.01% 2637
2014
Q1
$267 Sell
12,922
-248
-2% -$4.92K ﹤0.01% 2518
2013
Q4
$170 Buy
13,170
+11,244
+584% +$156K ﹤0.01% 2818
2013
Q3
$22 Buy
1,926
+1,476
+328% +$12.1K ﹤0.01% 3193
2013
Q2
$2K Buy
+450
New +$1.65K ﹤0.01% 3421

Other funds holding INSY

Manulife (Manufacturers Life Insurance)'s INSY Position: Q2 2019 in Review

Manulife (Manufacturers Life Insurance) sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 12,362 shares — an estimated $57K sold.

Manulife (Manufacturers Life Insurance) first reported a position in INSY in Q2 2013 and held it in 24 quarters. The position peaked at $274K in Q2 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Manulife (Manufacturers Life Insurance) reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 12,362 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $57K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Insys Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
  • Manulife (Manufacturers Life Insurance)'s Insys Therapeutics, Inc. position peaked at $274K in Q2 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2019, filed 14 Aug 2019.